z-logo
open-access-imgOpen Access
Retinal and Ocular Toxicity in Ocular Application of Drugs and Chemicals – Part II: Retinal Toxicity of Current and New Drugs
Author(s) -
Fernando M. Penha,
Eduardo B. Rodrigues,
Maurício Maia,
Bruno Furlani,
Caio V. Regatieri,
Gustavo Barreto Melo,
Octaviano Magalhães,
Roberta Munhoz Manzano,
Michel Eid Farah
Publication year - 2010
Publication title -
ophthalmic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 54
eISSN - 1423-0259
pISSN - 0030-3747
DOI - 10.1159/000316695
Subject(s) - medicine , pharmacology , toxicity , endophthalmitis , netilmicin , tobramycin , ophthalmology , antibiotics , gentamicin , biology , microbiology and biotechnology
Retinal pharmacotherapy has gained great importance for the treatment of various retinal diseases. An increasing number of drugs have been constantly released into the market, especially for wet age-related macular disease and diabetic macular edema. In this review, the issues concerning the toxicity of current and new classes of drugs are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom